BROADVIEW INC. — History
CCN 051991 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$2M
Latest Revenue (FY2022)
-13.3%
Revenue CAGR (3yr)
-100.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $2M | $2M | $2M | -1.2% | -13.3% |
| Operating Expenses | $4M | $4M | $4M | -0.4% | -5.4% |
| Operating Margin | -100.0% | -100.0% | -100.0% | +0.0% | +0.0% |
| Net Income | $-2M | $-2M | $-2M | -0.2% | +0.0% |
| Licensed Beds | 25 | 28 | 27 | -3.6% | +3.9% |
| Total Patient Days | 2,137 | 1,785 | 1,948 | +9.1% | -4.5% |
| Medicare Day % | 12% | 20% | 17% | -15.9% | +15.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -24.8% ($2M → $2M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-13.3%
This Hospital
+7.6%
State Avg
Latest Margin
-100.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1M | -100.0% |
| FY2024 (proj) | $1M | -100.0% |
| FY2025 (proj) | $1M | -100.0% |